UPDATE : Wednesday, January 17, 2018
Dizziness, headache added to precautions for Lixiana by Lee Hye-seon 2017-10-25 17:50
Korea’s high drug to medical expense ratio needs remedial steps by Lee Han-soo 2017-10-25 10:37
Huons to proceed with phase 3 clinical trials for dry eye treatment by Lee Han-soo 2017-10-24 17:56
Drugmakers to adopt anti-bribery management system ‘ISO 37001’ by Lee Hye-seon 2017-10-24 15:59
Roche Korea vows to put patients’ needs first by Marian Chu 2017-10-24 11:11
GSK gets US approval for shingles vaccine by Marian Chu 2017-10-24 10:15
Sanofi-Regeneron proves safety of cholesterol drug by Marian Chu 2017-10-23 15:32
Korean pharmaceuticals vie to preempt dry eye treatment market by Lee Hye-seon 2017-10-23 15:31
Novartis Korea increases cost-effectiveness of psoriasis drug by Marian Chu 2017-10-20 17:48
Bullous pemphigoid added to precautions for DPP-4 inhibitors by Lee Hye-seon 2017-10-20 16:02
Roche Korea is Korea’s 8th-best employer this year by Marian Chu 2017-10-20 13:31
AstraZeneca Korea denies rumors on stopping price talks by Marian Chu 2017-10-20 11:46
GSK Korea says its HPV vaccine reaches 89% effectiveness by Marian Chu 2017-10-19 15:56
Green Cross starts to develop high-dose flu vaccine for seniors by Lee Han-soo 2017-10-19 14:50
LG Chem launches Korea’s 1st combination drug for diabetes, dyslipidemia by Lee Han-soo 2017-10-19 14:43
FDA approves second CAR-T therapy to treat lymphoma by Marian Chu 2017-10-19 11:26
Will AstraZeneca pull lung cancer drug off Korean market? by Marian Chu 2017-10-18 17:52
Huons to go ahead with phase 3 clinical trial for Hutox by Lee Han-soo 2017-10-18 16:12
‘Poziotinib effective for rare non-small-cell lung cancer’ by Lee Hye-seon 2017-10-18 15:45
Daewoong unveils clinical trial results of expectorants treatment by Lee Han-soo 2017-10-18 14:09
Back to Top